A first-in-human safety and tolerability study of Patiromer in healthy subjects.

Trial Profile

A first-in-human safety and tolerability study of Patiromer in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 May 2016

At a glance

  • Drugs Patiromer (Primary)
  • Indications Hyperkalaemia
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 22 May 2016 According to a Relypsa media release, data from this trial were presented at the 53rd Congress of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA).
    • 22 May 2016 Results published in the Relypsa media release.
    • 28 Apr 2016 Results of new analyses from this and another phase I trial (CT profile 268636) published in a Relypsa Inc. media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top